@article{AOB4272,
author = {Veronica H. Flood and Thomas C. Abshire and Pamela A. Christopherson and Kenneth D. Friedman and Joan Cox Gill and Robert R. Montgomery and Sandra L. Haberichter and the Zimmerman Program Investigators},
title = {Von Willebrand disease in the United States: perspective from the Zimmerman program},
journal = {Annals of Blood},
volume = {3},
number = {1},
year = {2018},
keywords = {},
abstract = {This article will discuss the diagnosis and management of von Willebrand disease (VWD) in the United States and results from the Zimmerman Program, a national study of VWD. An algorithm is presented to show how we currently approach diagnostic testing for VWD, including the potential replacement of the ristocetin cofactor assay with a new von Willebrand factor (VWF)-GPIb binding assay. Results from the Zimmerman Program type 1 cohort are presented, including the findings that genetic defects in the VWF gene are most common with VWF levels },
issn = {2521-361X}, url = {https://aob.amegroups.org/article/view/4272}
}